UPDATE: Citigroup Raises Target to $27 on Molex


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Citigroup reiterates its Neutral rating on Molex (NASDAQ: MOLX) based choppy macro currents and resulting weak company results, but raises its price target to $27 from $25 on an adjusted valuation multiple. Citigroup says, "Molex reported FQ2'12 (Dec) Sales/EPS of $858m/$0.36, below consensus of $890m/$0.41 & guidance for $870-$910m/$0.37-$0.43. Management cited uncertain economic conditions, supply chain disruptions from the Thailand flood & inventory adjustments at customers/distribution as reasons for the disappointing quarter. Our target price goes to $27 from $25 despite the lowered outlook as the market multiple is at 13x vs 11.9x previously."MOLX closed at $26.52 a share yesterday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsCitigroup